Vectorious Medical Technologies
Mika Maayan began their work experience in 2011 as a Training Officer for the Israel Defense Forces and held this position until 2013. In 2017, they became a Manager for Perach - Tutorial Project, where they worked until 2018. Following this, Mika joined QuantalX as a Research Assistant from 2018 to 2019. In 2019, they joined Vectorious Medical Technologies as a Research and Development Engineer, and later became Head of Support in 2021. Currently, Mika holds the position of Product Manager at Vectorious Medical Technologies, starting in 2023.
Mika Maayan attended Tel Aviv University from 2015 to 2019, where they pursued an Engineer's degree in Biomedical/Medical Engineering.
This person is not in any offices
Vectorious Medical Technologies
1 followers
Vectorious Medical Technologies developed the V-LAP, the worlds first in-heart microcomputer which enables optimal treatment for heart failure patients, increasing their quality of life and life expectancy.The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. Itmonitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration.Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020.